Long-term analysis of prognostic risk factors impacting surgical outcomes in patients with external auditory canal carcinoma.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 02 12 2022
accepted: 14 02 2023
medline: 15 5 2023
pubmed: 23 2 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

Malignant neoplasms of the external auditory canal (EAC) are rare. No consensus on management has emerged. To determine possible risk factors influencing tumorgenesis and prognosis of EAC carcinoma. 108 patients (87 men/21 women) with an average age of 74 ± 13.8 years were recruited from 2005 to 2019 at Department of Otorhinolaryngology, Head and Neck Surgery Heidelberg. The follow-up interval was 43.62 ± 55.39 months. Partial and (sub)total ablative otis, supplementary surgery (petrosectomy, parotidectomy, neck dissection, mastoidectomy) and adjuvant radio(chemo)therapy belonged to treatment options. TNM status was determined at time of diagnosis using the AJCC staging system. 63.9% of patients underwent a total ablative otis. Tumor recurrence was seen in 24.1%. The 1-year survival rate was 87%, the 5-year survival rate was 52%, the mean overall survival (OS) was 3.82 ± 4.6 years. Male EAC carcinoma patients had a better OS (p < 0.001), PFS (p < 0.001) and DSS (p = 0.02) than females. T1 patients had a better OS (p = 0.01), PFS (p = 0.01) and DSS (p < 0.001) than T4 patients. Lymph node but not distant metastasis, tumor grading, perineural, venous and lymphatic invasion, histology, age and tumor localization influenced the OS in EAC carcinoma patients (p = 0.04). The more radical the ablative otis, the worse the OS (p = 0.002), PFS (p = 0.02) and DSS (p < 0.001). Radio(chemo)therapy did not improve the OS. EAC carcinoma are difficult to treat and benefit from early diagnosis so that a radical combined treatment approach does not need to be used.

Sections du résumé

BACKGROUND BACKGROUND
Malignant neoplasms of the external auditory canal (EAC) are rare. No consensus on management has emerged.
OBJECTIVE OBJECTIVE
To determine possible risk factors influencing tumorgenesis and prognosis of EAC carcinoma.
MATERIALS AND METHODS METHODS
108 patients (87 men/21 women) with an average age of 74 ± 13.8 years were recruited from 2005 to 2019 at Department of Otorhinolaryngology, Head and Neck Surgery Heidelberg. The follow-up interval was 43.62 ± 55.39 months. Partial and (sub)total ablative otis, supplementary surgery (petrosectomy, parotidectomy, neck dissection, mastoidectomy) and adjuvant radio(chemo)therapy belonged to treatment options. TNM status was determined at time of diagnosis using the AJCC staging system.
RESULTS RESULTS
63.9% of patients underwent a total ablative otis. Tumor recurrence was seen in 24.1%. The 1-year survival rate was 87%, the 5-year survival rate was 52%, the mean overall survival (OS) was 3.82 ± 4.6 years. Male EAC carcinoma patients had a better OS (p < 0.001), PFS (p < 0.001) and DSS (p = 0.02) than females. T1 patients had a better OS (p = 0.01), PFS (p = 0.01) and DSS (p < 0.001) than T4 patients. Lymph node but not distant metastasis, tumor grading, perineural, venous and lymphatic invasion, histology, age and tumor localization influenced the OS in EAC carcinoma patients (p = 0.04). The more radical the ablative otis, the worse the OS (p = 0.002), PFS (p = 0.02) and DSS (p < 0.001). Radio(chemo)therapy did not improve the OS.
CONCLUSIONS CONCLUSIONS
EAC carcinoma are difficult to treat and benefit from early diagnosis so that a radical combined treatment approach does not need to be used.

Identifiants

pubmed: 36806747
doi: 10.1007/s00405-023-07890-5
pii: 10.1007/s00405-023-07890-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2965-2974

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Carvalho CP, Barcellos AN, Teixeira DC, de Oliveira SJ, da Silva NR (2008) Adenoid cystic carcinoma of the external auditory canal. Braz J Otorhinolaryngol 74(5):794–796. https://doi.org/10.1016/S1808-8694(15)31394-X
doi: 10.1016/S1808-8694(15)31394-X pubmed: 19082366
Chang CH, Shu MT, Lee JC, Leu YS, Chen YC, Lee KS (2009) Treatments and outcomes of malignant tumors of external auditory canal. Am J Otolaryngol 30(1):44–48. https://doi.org/10.1016/j.amjoto.2008.02.007
doi: 10.1016/j.amjoto.2008.02.007 pubmed: 19027512
Lobo D, Llorente JL, Suarez C (2008) Squamous cell carcinoma of the external auditory canal. Skull Base 18(3):167–172. https://doi.org/10.1055/s-2007-994290
doi: 10.1055/s-2007-994290 pubmed: 18978963 pmcid: 2459330
Allanson BM, Low T-H, Clark JR, Gupta R (2018) Squamous cell carcinoma of the external auditory canal and temporal bone: an update. Head Neck Pathol 12(3):407–418. https://doi.org/10.1007/s12105-018-0908-4
doi: 10.1007/s12105-018-0908-4 pubmed: 30069837 pmcid: 6081282
Gandhi AK, Roy S, Biswas A, Raza MW, Saxena T, Bhasker S, Sharma A, Thakar A, Mohanti BK (2016) Treatment of squamous cell carcinoma of external auditory canal: a tertiary cancer centre experience. Auris Nasus Larynx 43(1):45–49. https://doi.org/10.1016/j.anl.2015.06.005
doi: 10.1016/j.anl.2015.06.005 pubmed: 26165629
Lobo D, Llorente JL, Suárez C (2008) Squamous cell carcinoma of the external auditory canal. Skull Base 18(3):167–172. https://doi.org/10.1055/s-2007-994290
doi: 10.1055/s-2007-994290 pubmed: 18978963 pmcid: 2459330
Morita S, Mizumachi T, Nakamaru Y, Sakashita T, Kano S, Hoshino K, Fukuda A, Fujiwara K, Homma A (2018) Comparison of the University of Pittsburgh staging system and the eighth edition of the American Joint Committee on Cancer TNM classification for the prognostic evaluation of external auditory canal cancer. Int J Clin Oncol 23 (6):1029–1037. https://doi.org/10.1007/s10147-018-1314-3
Zhang T, Dai C, Wang Z (2013) The misdiagnosis of external auditory canal carcinoma. Eur Arch Otorhinolaryngol 270(5):1607–1613. https://doi.org/10.1007/s00405-012-2159-4
doi: 10.1007/s00405-012-2159-4 pubmed: 22926989
Park JM, Kong JS, Chang KH, Jun BC, Jeon EJ, Park SY, Park SN, Park KH (2018) The clinical characteristics and surgical outcomes of carcinoma of the external auditory canal: a multicenter study. J Int Adv Otol 14(2):278–284. https://doi.org/10.5152/iao.2018.4952
doi: 10.5152/iao.2018.4952 pubmed: 30256202 pmcid: 6354453
Prasad S, Janecka IP (1994) Efficacy of surgical treatments for squamous cell carcinoma of the temporal bone: a literature review. Otolaryngol Head Neck Surg 110(3):270–280. https://doi.org/10.1177/019459989411000303
doi: 10.1177/019459989411000303 pubmed: 8134137
Wanner B, Rismiller K, Carr DR (2022) Treatment and survival outcomes of ceruminous carcinomas of the external auditory canal: a SEER database analysis and literature review. Arch Dermatol Res 314(6):583–591. https://doi.org/10.1007/s00403-021-02257-4
doi: 10.1007/s00403-021-02257-4 pubmed: 34160677
Mazzoni A, Danesi G, Zanoletti E (2014) Primary squamous cell carcinoma of the external auditory canal: surgical treatment and long-term outcomes. Acta otorhinolaryngologica Italica: organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 34(2):129–137
pubmed: 24843224
Schwager K, Pfreundner L Fau - Hoppe F, Hoppe F Fau - Baier G, Baier G Fau - Willner J, Willner J Fau - Baier K, Baier K [Carcinoma of the external ear canal and middle ear as interdisciplinary challenge for ear surgery and radiotherapy] (Das Karzinom des äusseren Gehörgangs und des Mittelohres als interdisziplinäre Herausforderung für Otochirurgie und Strahlentherapie.). (0935–8943 (Print))
Ostrowski VB, Wiet RJ (1996) Pathologic conditions of the external ear and auditory canal. Postgrad Med 100 (3):223–228, 233–227. https://doi.org/10.3810/pgm.1996.09.79
Visnyei K, Gill R, Azizi E, Culliney B (2013) Squamous cell carcinoma of the external auditory canal: a case report and review of the literature. Oncol Lett 5(5):1587–1590. https://doi.org/10.3892/ol.2013.1241
doi: 10.3892/ol.2013.1241 pubmed: 23761823 pmcid: 3678866
Smit CF, de Boer N, Lissenberg-Witte BI, Merkus P, Hensen EF, Leemans CR (2021) Surgical treatment for squamous cell carcinoma of the temporal bone: predictors of survival. Acta otorhinolaryngologica Italica: organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 41(4):308–316. https://doi.org/10.14639/0392-100X-N1074
doi: 10.14639/0392-100X-N1074 pubmed: 34533534
Shinomiya H, Uehara N, Teshima M, Kakigi A, Otsuki N, Nibu KI (2019) Clinical management for T1 and T2 external auditory canal cancer. Auris Nasus Larynx 46(5):785–789. https://doi.org/10.1016/j.anl.2019.02.004
doi: 10.1016/j.anl.2019.02.004 pubmed: 30799138
Prabhu R, Hinerman RW, Indelicato DJ, Morris CG, Werning JW, Vaysberg M, Amdur RJ, Kirwan J, Mendenhall WM (2009) Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy. Am J Clin Oncol 32(4):401–404. https://doi.org/10.1097/COC.0b013e31818f2d48
doi: 10.1097/COC.0b013e31818f2d48 pubmed: 19398900
Fleiner F, Jumah M, Göktas O (2009) Cancer of the external auditory canal-diagnostic and treatment. Indian J Otolaryngol Head Neck Surg 61(4):270–274. https://doi.org/10.1007/s12070-009-0081-x
doi: 10.1007/s12070-009-0081-x pubmed: 23120649
Madsen AR, Gundgaard MG, Hoff CM, Maare C, Holmboe P, Knap M, Thomsen LL, Buchwald C, Hansen HS, Bretlau P, Grau C (2008) Cancer of the external auditory canal and middle ear in Denmark from 1992 to 2001. Head Neck 30(10):1332–1338. https://doi.org/10.1002/hed.20877
doi: 10.1002/hed.20877 pubmed: 18704969
Correia-Rodrigues PA-O, Ramalho S, Montalvão P, Magalhães M External auditory canal carcinoma: clinical characteristics and long-term treatment outcomes. (1434–4726 (Electronic))
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67 (2):93–99. https://doi.org/10.3322/caac.21388
Work G, Invited R, Kim JYS, Kozlow JH, Mittal B, Moyer J, Olencki T, Rodgers P (2018) Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol 78(3):540–559. https://doi.org/10.1016/j.jaad.2017.10.006
doi: 10.1016/j.jaad.2017.10.006
Nam GS, Moon IS, Kim JH, Kim SH, Choi JY, Son EJ (2018) Prognostic factors affecting surgical outcomes in squamous cell carcinoma of external auditory canal. Clin Exp Otorhinolaryngol 11(4):259–266. https://doi.org/10.21053/ceo.2017.01340
doi: 10.21053/ceo.2017.01340 pubmed: 29779363 pmcid: 6222191
Arriaga M, Curtin H, Takahashi H, Hirsch BE, Kamerer DB (1990) Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol 99(9 Pt 1):714–721. https://doi.org/10.1177/000348949009900909
doi: 10.1177/000348949009900909 pubmed: 2396807
Moody SA, Hirsch BE, Myers EN (2000) Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system. Am J Otol 21(4):582–588
pubmed: 10912706
Lassig AA, Spector ME, Soliman S, El-Kashlan HK (2013) Squamous cell carcinoma involving the temporal bone: lateral temporal bone resection as primary intervention. Otol Neurotol 34(1):141–150. https://doi.org/10.1097/MAO.0b013e318278bf38
doi: 10.1097/MAO.0b013e318278bf38 pubmed: 23202152
Ihler F, Koopmann M, Weiss BG, Droge LH, Durisin M, Christiansen H, Weiss D, Canis M, Wolff HA (2015) Surgical margins and oncologic results after carcinoma of the external auditory canal. Laryngoscope 125(9):2107–2112. https://doi.org/10.1002/lary.25381
doi: 10.1002/lary.25381 pubmed: 26014051
Wang Z, Zheng M, Xia S (2016) The contribution of CT and MRI in staging, treatment planning and prognosis prediction of malignant tumors of external auditory canal. Clin Imaging 40(6):1262–1268. https://doi.org/10.1016/j.clinimag.2016.08.020
doi: 10.1016/j.clinimag.2016.08.020 pubmed: 27639864
Leong SC, Youssef A, Lesser TH (2013) Squamous cell carcinoma of the temporal bone: outcomes of radical surgery and postoperative radiotherapy. Laryngoscope 123(10):2442–2448. https://doi.org/10.1002/lary.24063
doi: 10.1002/lary.24063 pubmed: 23553471
Mazzoni A, Danesi G, Zanoletti E (2014) Primary squamous cell carcinoma of the external auditory canal: surgical treatment and long-term outcomes. Acta Otorhinolaryngol Ital 34(2):129–137
pubmed: 24843224 pmcid: 4025180
Essig GF, Kitipornchai L, Adams F, Zarate D, Gandhi M, Porceddu S, Panizza B (2013) Lateral temporal bone resection in advanced cutaneous squamous cell carcinoma: report of 35 patients. J Neurol Surg B Skull Base 74(1):54–59. https://doi.org/10.1055/s-0032-1331021
doi: 10.1055/s-0032-1331021 pubmed: 24436889
Breen JT, Roberts DB, Gidley PW (2018) Basal cell carcinoma of the temporal bone and external auditory canal. Laryngoscope 128(6):1425–1430. https://doi.org/10.1002/lary.26785
doi: 10.1002/lary.26785 pubmed: 28850700
Hahn SS, Kim JA, Goodchild N, Constable WC (1983) Carcinoma of the middle ear and external auditory canal. Int J Radiat Oncol Biol Phys 9(7):1003–1007. https://doi.org/10.1016/0360-3016(83)90388-7
doi: 10.1016/0360-3016(83)90388-7 pubmed: 6305893
Oya R, Takenaka Y, Takemura K, Ashida N, Shimizu K, Kitamura T, Yamamoto Y, Uno A (2017) Surgery with or without postoperative radiation therapy for early-stage external auditory canal squamous cell carcinoma: a meta-analysis. Otol Neurotol 38(9):1333–1338. https://doi.org/10.1097/MAO.0000000000001533
doi: 10.1097/MAO.0000000000001533 pubmed: 28796084
Shih L, Crabtree JA (1990) Carcinoma of the external auditory canal: an update. Laryngoscope 100(11):1215–1218. https://doi.org/10.1288/00005537-199011000-00016
doi: 10.1288/00005537-199011000-00016 pubmed: 2233086
Nyrop M, Grontved A (2002) Cancer of the external auditory canal. Arch Otolaryngol Head Neck Surg 128(7):834–837. https://doi.org/10.1001/archotol.128.7.834
doi: 10.1001/archotol.128.7.834 pubmed: 12117346
Nakagawa T, Kumamoto Y, Natori Y, Shiratsuchi H, Toh S, Kakazu Y, Shibata S, Nakashima T, Komune S (2006) Squamous cell carcinoma of the external auditory canal and middle ear: an operation combined with preoperative chemoradiotherapy and a free surgical margin. Otol Neurotol 27 (2):242–248; discussion 249. https://doi.org/10.1097/01.mao.0000190463.88873.3d
Takenaka Y, Cho H, Nakahara S, Yamamoto Y, Yasui T, Inohara H (2015) Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: a meta-analysis. Head Neck 37(7):1073–1080. https://doi.org/10.1002/hed.23698
doi: 10.1002/hed.23698 pubmed: 24692266
Boamah H, Knight G, Taylor J, Palka K, Ballard B (2011) Squamous cell carcinoma of the external auditory canal: a case report. Case Rep Otolaryngol 2011:615210. https://doi.org/10.1155/2011/615210
doi: 10.1155/2011/615210 pubmed: 22937370 pmcid: 3420775

Auteurs

Vera Lohnherr (V)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Ruprecht-Karls-University, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Niklas Wurzrainer (N)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Ruprecht-Karls-University, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Matthias Sand (M)

GESIS-Leibniz-Institute for the Social Sciences, Mannheim, Germany.

Philippe Federspil (P)

Department of Otorhinolaryngology, Head and Neck Surgery, Westpfalz Clinic, Kaiserslautern, Germany.

Jochen Hess (J)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Ruprecht-Karls-University, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Karim Zaoui (K)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Ruprecht-Karls-University, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Michaela Plath (M)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Ruprecht-Karls-University, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. Michaela.Plath@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH